Watson gains FDA approval for generic Revatio

Watson gains FDA approval for generic Revatio
US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) has received approval from the US Food and Drug Administration for its Abbreviated New Drug Application for sildenafil, the generic equivalent to global pharma behemoth Pfizer's (NYSE: PFE) …

Full News here – Read more on The Pharma Letter

Leave a Reply